Reynolds Cameron John, President and CEO of VolitionRx Ltd. ($VNRX), made seven open market purchases totaling nearly $240,000 over the past year, with the most recent on November 17, 2025. His activity ranks 1,404th among nearly 5,000 insiders in our database, where the average buy is $1.46 million across about 3.3 transactions. He reported no open market sales in the last 365 days.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 26, 2026 | VOLITIONRX LTD | $VNRX | Reynolds Cameron John | President and CEO | A | Common Stock | 486000 | $0.00 | 4,157,341.0000 | 122,801,572 | 13.24% | 0.40% |
| Jan. 22, 2026 | VOLITIONRX LTD | $VNRX | Reynolds Cameron John | President and CEO | A | Common Stock | 74700 | $0.00 | 3,671,341.0000 | 122,801,572 | 2.08% | 0.06% |
| Nov. 17, 2025 | VOLITIONRX LTD | $VNRX | Reynolds Cameron John | President and CEO | P | Common Stock | 20000 | $0.35 | 3,596,641.0000 | 122,801,572 | 0.56% | 0.02% |
| Oct. 14, 2025 | VOLITIONRX LTD | $VNRX | Reynolds Cameron John | President and CEO | P | Warrant (Right to Buy) | 110000 | $0.01 | 110,000.0000 | 96,543,744 | 9999.99% | 0.11% |
| Oct. 14, 2025 | VOLITIONRX LTD | $VNRX | Reynolds Cameron John | President and CEO | P | Common Stock | 110000 | $0.51 | 3,576,641.0000 | 96,543,744 | 3.17% | 0.11% |
| Sept. 12, 2025 | VOLITIONRX LTD | $VNRX | Reynolds Cameron John | President and CEO | P | Common Stock | 15000 | $0.66 | 3,666,641.0000 | 96,543,744 | 0.41% | 0.02% |
| Aug. 5, 2025 | VOLITIONRX LTD | $VNRX | Reynolds Cameron John | President and CEO | P | Common Stock | 78125 | $0.64 | 3,651,641.0000 | 96,543,744 | 2.19% | 0.08% |
| July 24, 2025 | VOLITIONRX LTD | $VNRX | Reynolds Cameron John | President and CEO | A | Common Stock | 200000 | $0.00 | 3,573,516.0000 | 96,543,744 | 5.93% | 0.21% |
| June 12, 2025 | VOLITIONRX LTD | $VNRX | Reynolds Cameron John | President and CEO | P | Common Stock | 12500 | $0.59 | 3,373,516.0000 | 96,543,744 | 0.37% | 0.01% |
| May 19, 2025 | VOLITIONRX LTD | $VNRX | Reynolds Cameron John | President and CEO | P | Common Stock | 20000 | $0.44 | 3,361,016.0000 | 96,543,744 | 0.60% | 0.02% |
| March 26, 2025 | VOLITIONRX LTD | $VNRX | Reynolds Cameron John | President and CEO | P | Common Stock | 181818 | $0.55 | 3,341,016.0000 | 96,543,744 | 5.76% | 0.19% |
| Jan. 29, 2025 | VOLITIONRX LTD | $VNRX | Reynolds Cameron John | President and CEO | A | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 29, 2025 | VOLITIONRX LTD | $VNRX | Reynolds Cameron John | President and CEO | D | Stock Option (Right to Buy) | 50000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Dec. 9, 2024 | VOLITIONRX LTD | $VNRX | Reynolds Cameron John | President and CEO | P | Common Stock | 139811 | $0.57 | 3,159,198.0000 | 0 | 4.63% | 0.00% |
| Sept. 1, 2024 | VOLITIONRX LTD | $VNRX | Reynolds Cameron John | President and CEO | A | Common Stock | 103243 | $0.00 | 3,019,387.0000 | 0 | 3.54% | 0.00% |
| Aug. 15, 2024 | VOLITIONRX LTD | $VNRX | Reynolds Cameron John | President and CEO | A | Common Stock | 29500 | $0.00 | 2,916,144.0000 | 0 | 1.02% | 0.00% |
| June 1, 2024 | VOLITIONRX LTD | $VNRX | Reynolds Cameron John | President and CEO | A | Common Stock | 90182 | $0.00 | 2,886,644.0000 | 0 | 3.22% | 0.00% |
| Jan. 24, 2024 | VOLITIONRX LTD | $VNRX | Reynolds Cameron John | President and CEO | A | Common Stock | 50150 | $0.00 | 2,796,462.0000 | 0 | 1.83% | 0.00% |